The role of brain natriuretic peptide in predicting renal outcome and fluid management in critically ill patients

Journal of the Formosan Medical Association

Volumn 114, Issue 12, 2015, Pages 1187-1196

  Chou, Yu Hsiang ^a,b   Chen, Yen Fu ^a   Pan, Szu Yu ^a,b   Huang, Tao Min ^a   Yang, Feng Jung ^a   Shen, Wen Ching ^a,b   Chen, Yung Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Acute kidney injury; Brain natriuretic peptide; Fluid therapy; Intensive care unit; Mortality

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DELTA BRAIN NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE COURSE; FEMALE; FLUID RESUSCITATION; FLUID THERAPY; HEART DISEASE; HUMAN; HYPERVOLEMIA; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK FACTOR; SEPSIS; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; BLOOD; CRITICAL ILLNESS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL MODEL; TAIWAN; TREATMENT OUTCOME; VERY ELDERLY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; BIOMARKERS; CRITICAL ILLNESS; FEMALE; FLUID THERAPY; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROSPECTIVE STUDIES; SEPSIS; TAIWAN; TREATMENT OUTCOME;

EID: 84983093998     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2015.10.015     Document Type: Article

References (41)

1. Hoste E.A., Schurgers M. Epidemiology of acute kidney injury: How big is the problem?. Crit Care Med 2008, 36:S146-S151.
2. Ali T., Khan I., Simpson W., Prescott G., Townend J., Smith W., et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 2007, 18:1292-1298.
3. Chen Y.C., Tsai F.C., Fang J.T., Yang C.W. Acute kidney injury in adults receiving extracorporeal membrane oxygenation. J Formos Med Assoc 2014, 113:778-785.
4. Payen D., de Pont A.C., Sakr Y., Spies C., Reinhart K., Vincent J.L. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008, 12:R74.
5. Bouchard J., Soroko S.B., Chertow G.M., Himmelfarb J., Ikizler T.A., Paganini E.P., et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009, 76:422-427.
6. Heung M., Wolfgram D.F., Kommareddi M., Hu Y., Song P.X., Ojo A.O. Fluid overload at initiation of renal replacement therapy is associated with lack of renal recovery in patients with acute kidney injury. Nephrol Dial Transplant 2012, 27:956-961.
7. Prowle J.R., Echeverri J.E., Ligabo E.V., Ronco C., Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol 2010, 6:107-115.
8. Prowle J.R., Kirwan C.J., Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol 2014, 10:37-47.
9. Chou Y.H., Chen Y.F., Lin S.L. More is not better: fluid therapy in critically ill patients with acute kidney injury. J Formos Med Assoc 2013, 112:112-114.
10. Azzazy H.M., Christenson R.H. B-type natriuretic peptide: physiologic role and assay characteristics. Heart Fail Rev 2003, 8:315-320.
11. Wang F., Wu Y., Tang L., Zhu W., Chen F., Xu T., et al. Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis. Crit Care 2012, 16:R74.
12. Papanikolaou J., Makris D., Mpaka M., Palli E., Zygoulis P., Zakynthinos E. New insights into the mechanisms involved in b-type natriuretic peptide elevation and its prognostic value in septic patients. Crit Care 2014, 18:R94.
13. Rawlins M.L., Owen W.E., Roberts W.L. Performance characteristics of four automated natriuretic peptide assays. Am J Clin Pathol 2005, 123:439-445.
14. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012, 120:c179-c184.
15. Levin A., Stevens P.E. Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 2014, 85:49-61.
16. Teixeira C., Garzotto F., Piccinni P., Brienza N., Iannuzzi M., Gramaticopolo S., et al. Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 2013, 17:R14.
17. Vaara S.T., Korhonen A.M., Kaukonen K.M., Nisula S., Inkinen O., Hoppu S., et al. Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study. Crit Care 2012, 16:R197.
18. Marik P.E., Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med 2013, 41:1774-1781.
19. Marik P.E., Cavallazzi R., Vasu T., Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med 2009, 37:2642-2647.
20. Kosiak W., Swieton D., Piskunowicz M. Sonographic inferior vena cava/aorta diameter index, a new approach to the body fluid status assessment in children and young adults in emergency ultrasound-preliminary study. Am J Emerg Med 2008, 26:320-325.
21. Muller L., Bobbia X., Toumi M., Louart G., Molinari N., Ragonnet B., et al. Respiratory variations of inferior vena cava diameter to predict fluid responsiveness in spontaneously breathing patients with acute circulatory failure: need for a cautious use. Crit Care 2012, 16:R188.
22. Wabel P., Chamney P., Moissl U., Jirka T. Importance of whole-body bioimpedance spectroscopy for the management of fluid balance. Blood Purif 2009, 27:75-80.
23. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Omland T., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004, 350:655-663.
24. Berger R., Moertl D., Peter S., Ahmadi R., Huelsmann M., Yamuti S., et al. N-terminal pro-b-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. J Am Coll Cardiol 2010, 55:645-653.
25. Parfrey P.S. BNP in hemodialysis patients. Clin J Am Soc Nephrol 2010, 5:954-955.
26. Crepaldi C., Rosner M., Teixeira C., Martos L.B., Martino F.K., Rodighiero M.P., et al. Is brain natriuretic peptide a reliable biomarker of hydration status in all peritoneal dialysis patients?. Blood Purif 2014, 37:238-242.
27. Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 2004, 6:257-260.
28. Tagore R., Ling L.H., Yang H., Daw H.Y., Chan Y.H., Sethi S.K. Natriuretic peptides in chronic kidney disease. Clin J Am Soc Nephrol 2008, 3:1644-1651.
29. de Cal M., Haapio M., Cruz D.N., Lentini P., House A.A., Bobek I., et al. B-type natriuretic peptide in the critically ill with acute kidney injury. Int J Nephrol 2011, 2011:951629.
30. Han S.S., Ahn S.Y., Ryu J., Baek S.H., Kim K.I., Chin H.J., et al. U-shape relationship of white blood cells with acute kidney injury and mortality in critically ill patients. Tohoku J Exp Med 2014, 232:177-185.
31. Walsh M., Garg A.X., Devereaux P.J., Argalious M., Honar H., Sessler D.I. The association between perioperative hemoglobin and acute kidney injury in patients having noncardiac surgery. Anesth Analg 2013, 117:924-931.
32. Darmon M., Diconne E., Souweine B., Ruckly S., Adrie C., Azoulay E., et al. Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change. Crit Care 2013, 17:R12.
33. Funk G.C., Lindner G., Druml W., Metnitz B., Schwarz C., Bauer P., et al. Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med 2010, 36:304-311.
34. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2012, 2013(41):580-637.
35. Meyer B., Huelsmann M., Wexberg P., Delle Karth G., Berger R., Moertl D., et al. N-terminal pro-b-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit Care Med 2007, 35:2268-2273.
36. Taccone F.S., Artigas A.A., Sprung C.L., Moreno R., Sakr Y., Vincent J.L. Characteristics and outcomes of cancer patients in European ICUs. Crit Care 2009, 13:R15.
37. Fuchs L., Chronaki C.E., Park S., Novack V., Baumfeld Y., Scott D., et al. ICU admission characteristics and mortality rates among elderly and very elderly patients. Intensive Care Med 2012, 38:1654-1661.
38. Nicholson J.P., Wolmarans M.R., Park G.R. The role of albumin in critical illness. Br J Anaesth 2000, 85:599-610.
39. Povoa P.R., Carneiro A.H., Ribeiro O.S., Pereira A.C. Influence of vasopressor agent in septic shock mortality. results from the Portuguese community-acquired sepsis study (SACIUCI study). Crit Care Med 2009, 37:410-416.
40. Visser P., Harriss L.R., Hart G.K., Bohensky M., Sundaresan L., Kennedy M. Factors involved in intensive care unit mortality following medical retrieval: identifying differences between intensive care unit survivors and non-survivors. Emerg Med Australas 2013, 25:260-267.
41. Salgado D.R., Silva E., Vincent J.L. Control of hypertension in the critically ill: a pathophysiological approach. Ann Intensive Care 2013, 3:17.